title: Relevance of pharmacokinetic differences between ACE inhibitors and their role in the treatment of hypertension.
authors.affiliation: Department of Clinical Pharmacology and Therapeutics, Austin Hospital, Heidelberg, Australia.
authors.forename: W J
authors.initials: WJ
authors.lastname: Louis
authors.forename: E L
authors.initials: EL
authors.lastname: Conway
authors.forename: C J
authors.initials: CJ
authors.lastname: O'Callaghan
authors.forename: E S
authors.initials: ES
authors.lastname: Louis
authors.forename: O
authors.initials: O
authors.lastname: Drummer
authors.forename: J J
authors.initials: JJ
authors.lastname: McNeil
authors.forename: L G
authors.initials: LG
authors.lastname: Howes
authors.forename: H
authors.initials: H
authors.lastname: Krum
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D003327:Coronary Disease / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors